ArticleJournal of the Endocrine Society2025

SGLT2 Inhibitors Modify Fibrosis-4 Index and Mitigate the Development of DKD: Role of Background Antidiabetic Drugs.

Keisuke Takano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.